Abstract:Background: 5-hydroxytryptophan (5-HTP), the direct biosynthetic precursor of the neurotransmitter 5-hydroxytryptamine, has been shown to have unique efficacy in the treatment of a variety of disorders, including depression, insomnia, and chronic headaches, and is one of the most commercially valuable amino acid derivatives. However, microbial fermentation for 5-HTP production continues to face many challenges, including low titer/yield and the presence of the intermediate L-tryptophan (L-Trp), owing to the complexity and low activity of heterologous expression in prokaryotes. Therefore, there is a need to construct an efficient microbial cell factory for 5-HTP production. Results: We describe the systematic modular engineering of wild-type Escherichia coli for the efficient fermentation of 5-HTP from glucose. First, a xylose-induced T7 RNA polymerase-PT7 promoter system was constructed to ensure the efficient expression of each key heterologous pathway in E. coli. Next, a new tryptophan hydroxylase mutant was used to construct an efficient tryptophan hydroxylation module, and the cofactor tetrahydrobiopterin synthesis and regeneration pathway was expressed in combination. The L-Trp synthesis module was constructed by modifying the key metabolic nodes of tryptophan biosynthesis, and the heterologous synthesis of 5-HTP was achieved. Finally, the NAD(P)H regeneration module was constructed by the moderate expression of the heterologous GDHesi pathway, which successfully reduced the surplus of the intermediate L-Trp. The final engineered strain HTP11 was able to produce 8.58 g/L 5-HTP in a 5-L bioreactor with a yield of 0.095 g/g glucose and a maximum real-time productivity of 0.48 g/L/h, the highest values reported by microbial fermentation. Conclusion: In this study, we demonstrate the successful design of a cell factory for high-level 5-HTP production, combined with simple processes that have potential for use in industrial applications in the future. Thus, this study provides a reference for the production of high-value amino acid derivatives using a systematic modular engineering strategy and a basis for an efficient engineered strain development of 5-HTP high-value derivatives.

Directed Evolution Improves the Enzymatic Synthesis of L-5-hydroxytryptophan by an Engineered Tryptophan Synthase

Engineering Improves Enzymatic Synthesis of L-Tryptophan by Tryptophan Synthase from Escherichia Coli

Compensation of the Enantioselectivity-Activity Trade-off in the Directed Evolution of an Esterase from Rhodobacter Sphaeroides by Site-Directed Saturation Mutagenesis

Engineering Escherichia Coli to Improve Tryptophan Production Via Genetic Manipulation of Precursor and Cofactor Pathways

Engineering of human tryptophan hydroxylase 2 for efficient synthesis of 5-hydroxytryptophan

Directed Evolution of Esterase for Advanced Enantioselectivity

Enzymatic Synthesis of L-5-Hydroxytryptophan Catalyzed by Tryptophan Synthase

Enhancing tryptophan production by balancing precursors in Escherichia coli

Ultrahigh Throughput Evolution of Tryptophan Synthase in Droplets via an Aptamer Sensor

Engineering of Shikimate Pathway and Terminal Branch for Efficient Production of L-Tryptophan in Escherichia coli

One-step of tryptophan attenuator inactivation and promoter swapping to improve the production of L-tryptophan in Escherichia coli

Rational Design of Tryptophan Hydroxylation 1 for Improving 5-Hydroxytryptophan Production.

Metabolic engineering of Escherichia coli for efficient production of L-5-hydroxytryptophan from glucose

Enhanced Production of 5-Hydroxytryptophan Through the Regulation of L-tryptophan Biosynthetic Pathway

Enhancing thermostability of tryptophan hydroxylase via protein engineering and its application in 5-hydroxytryptophan production

Enzymatic Synthesis of L-tryptophan from D,L-2-amino-Δ2-thiazoline-4-carboxylic Acid and Indole by Pseudomonas Sp. TS1138 L-2-amino-Δ2-thiazoline-4-carboxylic Acid Hydrolase, S-carbamyl-L-cysteine Amidohydrolase and Escherichia Coli L-tryptophanase

Enhanced Production of L-Tryptophan with Glucose Feeding and Surfactant Addition and Related Metabolic Flux Redistribution in the Recombinant Escherichia Coli

Enzymatic synthesis oF L-tryptophan from D,L-2-amino-delta2-thiazoline-4-carboxylic acid and indole by Pseudomonas sp. TS1138 L-2-amino-delta2-thiazoline-4-carboxylic acid hydrolase, S-carbamyl-L-cysteine amidohydrolase, and Escherichia coli L-tryptophanase

Metabolic Pathway Engineering for High-Level Production of 5-Hydroxytryptophan in Escherichia Coli.

Construction of cell factory capable of efficiently converting L-tryptophan into 5-hydroxytryptamine

Directed-evolution of Translation System for Efficient Unnatural Amino Acids Incorporation and Generalizable Synthetic Auxotroph Construction.